What We Do

Research

At INM, we support a broad range of scientific inquiries aimed at creating new diagnostics and therapies in nuclear medicine. Additionally, our focus includes optimizing existing treatments to make them safer and more effective for improving human health.
We believe in the importance of open science and the widespread dissemination of innovative findings, with the aim of translating research breakthroughs into practical healthcare applications.

Education

We teach, learn, and exchange knowledge, including through scientific gatherings, fellowships, and internships that support the advancement of radiopharmaceutical treatments. Our educational initiatives are designed to empower professionals and students, enhancing expertise and building a robust community of practice dedicated to excellence and innovation in the field.

Global Partnership

We engage in partnerships with organizations, communities, and individuals around the world to exchange knowledge, collaborate on innovative research, and implement effective strategies in radiopharmaceutical therapy. Our global network is committed to sharing best practices, fostering multidisciplinary approaches, and driving progress through international cooperation and mutual learning.

Health Policy and Patient Advocacy

INM is dedicated to putting patients at the forefront of its work, aiming to support sustainable initiatives in education, research, and business within the nuclear medicine field. We advocate for patients by developing clear positions on nuclear medicine practices and policies, and by providing direct feedback to federal agencies, ensuring patient interests are included in policy-making discussions.

Heptathlon of Sustainable Meaningful Access to RadioPharmaceutical Therapy (RPT 3.0)

(
1
)

Optimization of RPTs

Using theranostic imaging, dosimetry and computational nuclear oncology tools to enable predictive oncology and personalization of therapies, including digital twinning of patients (Theranostic Digital Twin)

(
2
)

Access Deficiency Discovery

Scientific identification of “lack of access” through multi-disciplinary investigation

(
3
)

Implementation and Dissemination

Utilizing Systems Science/Engineering to plan and implement a multi-dimensional solution to address the deficiencies in access.

(
4
)

Education

The core component of sustainability is training the next generation of nuclear medicine physicians/physicists/technologists inadvancing the discipline with the aim of helping patients in need - Resident/Fellow Education - NMT education - Medical Student - NM Medical Physicists - Data Scientists

(
5
)

Collaboration and Sharing

Only a community of physicians and other scientists can satisfy the needs of this complex evolution. The nuclear medicine community should embrace the essence of collaboration and enhance the culture of resource sharing (toward open data and open science).

(
6
)

Advocacy and Societal Interaction

Active engagement with governmental and non-governmental agencies and exercising responsible advocacy for the patients and their care team are of utmost importance to ensure resources are attracted to the practice of RPT.

(
7
)

Trustworthy Ecosystem

Last, but not least, is the importance of trust as the core tenet of patient care. We need to embrace the principles of trustworthiness and implement them in the ecosystem of radiopharmaceutical therapy and the nuclear medicine community